Cargando…

Scenarios in precision medicine: proteomics in heart failure

Proteomics in heart failure (HF) is aimed to study and identify proteins involved in the pathophysiology of this clinical syndrome. Proteins have a role as diagnostic, prognostic and therapeutic markers. This review will unravel the developments and impact of proteomics in HF, focusing on its role i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentile, Piero, Palazzini, Matteo, Garascia, Andrea, Oliva, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	CCC 2022 - State of the Art Cardiology Supplement Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653121/ https://www.ncbi.nlm.nih.gov/pubmed/36380813 http://dx.doi.org/10.1093/eurheartjsupp/suac083

Ejemplares similares

Advanced heart failure: from definitions to therapeutic options
por: Garascia, Andrea, et al.
Publicado: (2023)

Iron deficiency in heart failure: diagnosis and clinical implications
por: Del Pinto, Rita, et al.
Publicado: (2022)

Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossible
por: Sciatti, Edoardo, et al.
Publicado: (2022)

An aggressive solution for patients with heart failure and atrial fibrillation: nodal ablation and cardiac resynchronization therapy
por: Bianchi, Stefano, et al.
Publicado: (2022)

Cardiology of the future: xenotransplantation with porcine heart
por: Sinagra, Gianfranco, et al.
Publicado: (2022)

Association between heart and dementia… keep an eye on the left atrium
por: Terrosu, Pierfranco
Publicado: (2022)

On site cardiac surgery for structural heart interventions: a fence to mend?
por: Foglietta, Melissa, et al.
Publicado: (2022)

Echocardiography strain: why is it used more and more?
por: Cameli, Matteo
Publicado: (2022)

Computed tomography to replace invasive coronary angiography? The DISCHARGE trial
por: Bolognese, Leonardo, et al.
Publicado: (2022)

The treatment of amyloidosis is being refined
por: Cantone, Anna, et al.
Publicado: (2022)

The myocardial bridge: incidence, diagnosis, and prognosis of a pathology of uncertain clinical significance
por: Santucci, Andrea, et al.
Publicado: (2022)

Cardiac complications of COVID-19 vaccination: now we know more
por: Verdecchia, Paolo, et al.
Publicado: (2022)

Heart failure therapy: the fifth card
por: Balestrieri, Giulio, et al.
Publicado: (2023)

Polygenic risk score and age: an extra help in the cardiovascular prevention of the young?
por: Temporelli, Pier Luigi
Publicado: (2022)

Surgical approach to combined mitral and tricuspid valve disease: good neighbourhood rules
por: Ascione, Guido, et al.
Publicado: (2022)

Is it possible that angioplasty does not improve the quality of life in patients with stable angina?
por: Golino, Paolo
Publicado: (2022)

Post-infarct mitral insufficiency: when to resort to reparative surgery, when to the mitral clip
por: Gomez-Polo, Juan Carlos, et al.
Publicado: (2022)

Transcatheter mitral valve replacement: there is still work to be done
por: Bartorelli, Antonio L, et al.
Publicado: (2022)

Why can primary angioplastics be ineffective despite the precocity of the intervention?
por: Patti, Giuseppe, et al.
Publicado: (2022)

The point on the electronic cigarette more than 10 years after its introduction
por: Spoladore, Roberto, et al.
Publicado: (2022)

Is drinking wine in moderation good for health or not?
por: Poli, Andrea
Publicado: (2022)

Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
por: Rizzello, Vittoria
Publicado: (2022)

Clinical implications of cardiac magnetic resonance imaging fibrosis
por: Guglielmo, Marco, et al.
Publicado: (2022)

The risk of acute coronary events in microvascular disease
por: Varrichione, Giuseppe, et al.
Publicado: (2022)

When to set anticoagulant therapy in asymptomatic AF? looking for a cut-off duration
por: Rossini, Roberta, et al.
Publicado: (2022)

The enigma of resistant hypertension: from lifestyle changes and pharmacological treatment to renal denervation
por: Volpe, Massimo, et al.
Publicado: (2022)

‘Use of lipid-lowering therapy: the guidelines, the drugs or the patient?’
por: Borghi, Claudio, et al.
Publicado: (2022)

Reduction of cerebrovascular and peripheral events with PCSK9 inhibitors: Does it just depend on the lowering of the low-density lipoprotein?
por: Cesaro, Arturo, et al.
Publicado: (2022)

Clinical research methodology process: what has changed with COVID-19?
por: Tavazzi, Luigi
Publicado: (2022)

When Brugada syndrome is at risk of sudden death: clinical and anatomical aspects
por: Stazi, Filippo, et al.
Publicado: (2022)

Treatment in patients with severe asymptomatic aortic stenosis: is it best not to wait?
por: Di Pietro, Elena, et al.
Publicado: (2022)

The many NOs to the use of Class IC antiarrhythmics: weren’t the guidelines too strict?
por: Turturiello, Dario, et al.
Publicado: (2022)

The stent in the high-bleeding risk patient: antiplatelet monotherapy?
por: Capranzano, Piera
Publicado: (2022)

Some good reasons to proceed with the occlusion of the auricle
por: Casu, Gavino, et al.
Publicado: (2022)

Sodium–glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndrome
por: Cice, Gennaro, et al.
Publicado: (2022)

The link between influenza and myocardial infarction: vaccination protects
por: Bocale, Raffaella, et al.
Publicado: (2022)

Pollution and coronary risk: how much does it matter?
por: Muscente, Francesca, et al.
Publicado: (2022)

The percutaneous coronary angioplasty gets better, but the surgical coronary artery bypass does not stay behind
por: De Paulis, Ruggero, et al.
Publicado: (2022)

Role of lipoprotein(a) in plaque progression
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

Ischaemic stroke in the absence of documented atrial fibrillation: is there who could benefit from anticoagulant therapy?
por: Vassiliki’ Coutsoumbas, Gloria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4a9c6uqg2r1vte61rvm70tkfao